# ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™

> **NCT06608823** · NA · RECRUITING · sponsor: **JenaValve Technology, Inc.** · enrollment: 1016 (estimated)

## Conditions studied

- Aortic Regurgitation
- Aortic Valve Insufficiency
- Aortic Insufficiency

## Interventions

- **DEVICE:** Transcatheter Aortic Valve Replacement (TAVR) using Trilogy THV System
- **DEVICE:** SAVR

## Key facts

- **NCT ID:** NCT06608823
- **Lead sponsor:** JenaValve Technology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-18
- **Primary completion:** 2026-06
- **Final completion:** 2036-02
- **Target enrollment:** 1016 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06608823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06608823, "ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06608823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*